NCT04863248 2023-04-14
PRESERVE 4
G1 Therapeutics, Inc.
Phase 2 Terminated
G1 Therapeutics, Inc.
EMD Serono
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
Genentech, Inc.
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Instituto Nacional de Cancer, Brazil